BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 19281080)

  • 1. Skeletal muscle dysfunction in patients with chronic obstructive pulmonary disease.
    Kim HC; Mofarrahi M; Hussain SN
    Int J Chron Obstruct Pulmon Dis; 2008; 3(4):637-58. PubMed ID: 19281080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex differences in COPD-related quadriceps muscle dysfunction and fibre abnormalities.
    Sharanya A; Ciano M; Withana S; Kemp PR; Polkey MI; Sathyapala SA
    Chron Respir Dis; 2019; 16():1479973119843650. PubMed ID: 31131626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiology of muscle dysfunction in COPD.
    Gea J; Agustí A; Roca J
    J Appl Physiol (1985); 2013 May; 114(9):1222-34. PubMed ID: 23519228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular and biological research on respiratory muscle wasting in chronic obstructive pulmonary disease].
    Ju CR; Chen RC
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Aug; 30(8):613-5. PubMed ID: 17988560
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative assessment of the quadriceps and the diaphragm in patients with COPD.
    Caron MA; Debigaré R; Dekhuijzen PN; Maltais F
    J Appl Physiol (1985); 2009 Sep; 107(3):952-61. PubMed ID: 19359618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The rat model of COPD skeletal muscle dysfunction induced by progressive cigarette smoke exposure: a pilot study.
    Su J; Li J; Lu Y; Li N; Li P; Wang Z; Wu W; Liu X
    BMC Pulm Med; 2020 Mar; 20(1):74. PubMed ID: 32293377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Peripheral muscle dysfunction in chronic obstructive pulmonary disease].
    Roca M; Mihăescu T
    Pneumologia; 2012; 61(3):178-82. PubMed ID: 23173381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic and pulmonary inflammation is independent of skeletal muscle changes in patients with chronic obstructive pulmonary disease.
    Barker BL; McKenna S; Mistry V; Pancholi M; Patel H; Haldar K; Barer MR; Pavord ID; Steiner MC; Brightling CE; Bafadhel M
    Int J Chron Obstruct Pulmon Dis; 2014; 9():975-81. PubMed ID: 25246784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Respiratory muscle function and activation in chronic obstructive pulmonary disease.
    McKenzie DK; Butler JE; Gandevia SC
    J Appl Physiol (1985); 2009 Aug; 107(2):621-9. PubMed ID: 19390004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Last Word on Point:Counterpoint: The major limitation to exercise performance in COPD is 1) inadequate energy supply to the respiratory and locomotor muscles, 2) lower limb muscle dysfunction, 3) dynamic hyperinflation.
    O'Donnell D; Webb K
    J Appl Physiol (1985); 2008 Aug; 105(2):765. PubMed ID: 18678631
    [No Abstract]   [Full Text] [Related]  

  • 11. Last Word on Point:Counterpoint: The major limitation to exercise performance in COPD is 1) inadequate energy supply to the respiratory and locomotor muscles, 2) lower limb muscle dysfunction, 3) dynamic hyperinflation.
    Debigaré R; Maltais F
    J Appl Physiol (1985); 2008 Aug; 105(2):764. PubMed ID: 18678630
    [No Abstract]   [Full Text] [Related]  

  • 12. Last Word on Point:Counterpoint: The major limitation to exercise performance in COPD is 1) inadequate energy supply to the respiratory and locomotor muscles, 2) lower limb muscle dysfunction, 3) dynamic hyperinflation.
    Aliverti A; Macklem PT
    J Appl Physiol (1985); 2008 Aug; 105(2):763. PubMed ID: 18678629
    [No Abstract]   [Full Text] [Related]  

  • 13. Skeletal Muscle Dysfunction in Chronic Obstructive Pulmonary Disease. What We Know and Can Do for Our Patients.
    Jaitovich A; Barreiro E
    Am J Respir Crit Care Med; 2018 Jul; 198(2):175-186. PubMed ID: 29554438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dynamic hyperinflation -- the main mechanism of decreased exercise tolerance in patients with COPD].
    Gologanu D
    Pneumologia; 2013; 62(2):102-5. PubMed ID: 23894791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of autophagy in COPD skeletal muscle dysfunction.
    Hussain SN; Sandri M
    J Appl Physiol (1985); 2013 May; 114(9):1273-81. PubMed ID: 23085958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skeletal muscle apoptosis and weight loss in chronic obstructive pulmonary disease.
    Agustí AG; Sauleda J; Miralles C; Gomez C; Togores B; Sala E; Batle S; Busquets X
    Am J Respir Crit Care Med; 2002 Aug; 166(4):485-9. PubMed ID: 12186825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The major limitation to exercise performance in COPD is inadequate energy supply to the respiratory and locomotor muscles vs. lower limb muscle dysfunction vs. dynamic hyperinflation. The real cause of exercise limitation in COPD.
    Wagner PD
    J Appl Physiol (1985); 2008 Aug; 105(2):758. PubMed ID: 18678625
    [No Abstract]   [Full Text] [Related]  

  • 18. Ubiquitination and proteolysis in limb and respiratory muscles of patients with chronic obstructive pulmonary disease.
    Debigaré R; Côté CH; Maltais F
    Proc Am Thorac Soc; 2010 Feb; 7(1):84-90. PubMed ID: 20160153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of rehabilitative exercise training on peripheral muscle remodelling in patients with COPD: targeting beyond the lungs.
    Nasis I; Kortianou EA; Clini E; Koulouris NG; Vogiatzis I
    Curr Drug Targets; 2013 Feb; 14(2):262-73. PubMed ID: 23256723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscle metabolism and exercise tolerance in COPD.
    Polkey MI
    Chest; 2002 May; 121(5 Suppl):131S-135S. PubMed ID: 12010841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.